Acting as a “brake” or “accelerator” in tumor immune regulation, IDO1 induces immunosuppressive tumor microenvironment and enables cancer cells to escape immune surveillance by catabolizing tryptophan into tryptophan (41). This evidence concerns the gene IDO1 and cancer.